References
- Ferlay J, Bray F, Pisani P, Parkin D. GLOBOCAN 2002: Cancer incidence, mortality and prevalence worldwide. IARC Cancer Base No. 5, version 2.0. Lyon: IARC Press; 2004.
- Fellin G, Graffer U, Bolner A, Ambrosini G, Caffo O, Luciani L. Combined chemotherapy and radiation with selective organ preservation for muscle-invasive bladder carcinoma. A single-institution phase II study. Br J Urol 1997;80:44–9.
- Sherif A, Rintala E, Mestad O, Nilsson J, Holmberg L, Nilsson S, Neoadjuvant cisplatin–methotrexate chemotherapy for invasive bladder cancer – Nordic cystectomy trial 2. Scand J Urol Nephrol 2002;36:419–25.
- Vlahou A, Schellhammer PF, Mendrinos S, Patel K, Kondylis FI, Gong L, Development of a novel proteomic pproach for the detection of transitional cell carcinoma of the bladder in urine. Am J Pathol 2001;158:1491–502.
- Celis JE, Celis P, Palsdottir H, Ostergaard M, Gromov P, Primdahl H, Proteomic strategies to reveal tumor heterogeneity among urothelial papillomas. Mol Cell Proteomics 2002;1:269–79.
- Rasmussen HH, Orntoft TF, Wolf H, Celis JE. Towards a comprehensive database of proteins from the urine of patients with bladder cancer. J Urol 1996;155:2113–9.
- Celis JE, Ostergaard M, Basse B, Celis A, Lauridsen JB, Ratz GP, Loss of adipocyte-type fatty acid binding protein and other protein biomarkers is associated with progression of human bladder transitional cell carcinomas. Cancer Res 1996;56:4782–90.
- Wu TF, Wu H, Chow NH, Liao CF, Liu HS. Proteomic analysis of bladder cancer cells reveals potential candidates of biomarkers in bladder tumorigenesis. Cancer Genomics Proteomics 2005;2:151–8.
- Sheng KH, Yao YC, Chuang SS, Wu H, Wu TF. Search for the tumor-related proteins of transition cell carcinoma in Taiwan by proteomic analysis. Proteomics 2006;6:1058–65.
- Barboro P, Rubagotti A, Orecchia P, Spina B, Truini M, Repaci E, Differential proteomic analysis of nuclear matrix in muscle-invasive bladder cancer: potential to improve diagnosis and prognosis. Cell Oncol 2008;30:13–26.
- Iwadate Y. Clinical proteomics in cancer research – promises and limitations of current two-dimensional gel electrophoresis. Curr Med Chem 2008;15:2393–400.
- Molloy MP, Brzezinski EE, Hang J, McDowell MT, VanBogelen RA. Overcoming technical variation and biological variation in quantitative proteomics. Proteomics 2003;3:1912–9.
- Lopez-Beltran A. Bladder cancer: clinical and pathological profile. Scand J Urol Nephrol 2008;Suppl:95–109.
- Merril CR, Goldman D, Sedman SA, Ebert MH. Ultrasensitive stain for proteins in polyacrylamide gels shows regional variation in cerebrospinal fluid proteins. Science 1981;211:1437–8.
- Berth M, Moser FM, Kolbe M, Bernhardt J. The state of the art in the analysis of two-dimensional gel electrophoresis images. Appl Microbiol Biotechnol 2007;76:1223–43.
- Sanchez JC, Appel RD, Golaz O, Pasquali C, Ravier F, Bairoch A, Inside SWISS-2DPAGE database. Electrophoresis 1995;16:1131–51.